Hematology Research Unit Helsinki

Hematology Research Unit Helsinki (HRUH) is a translational research group, which aims to understand the pathobiology of malignant blood diseases (such as leukemia) and related autoimmune disorders and find novel therapy targets and modes of action. We combine basic cancer research with clinical drug studies and our long-term goal is to develop curative treatment strategies for patients.
Read more

Very grateful for continuous support for our #Heal-Art consortium from @AKA_ohjelmat. Together with @LahesmaaGrouptwitter.com/i/web/status/1…

Our work on the immunogenomic landscape of hematological malignancies out in the latest @Cancer_Cell (open access l… twitter.com/i/web/status/1…

Protect the European Research Council (ERC) in the EU budget - Sign the Petition! chng.it/mZsXdjR5 käyttäen @Change @ERC_Research

RUNX1 Mutations in the Context of Personalized Approach in Blast Phase Chronic Myeloid Leukemia cancercommunity.nature.com/posts/runx1-mu… #

Contact Information

Hematology Research Unit Helsinki, Biomedicum 1 • Haartmaninkatu 8 • P.O. Box 700, 00029 HUCH Finland • +358-9-471-71898 (tel) • +358-9-471-71955 (lab) • +358-9-471-71897 (fax) • E-mail: firstname.lastname@helsinki.fi